ZA200505639B - Process for preparing enantiomerically enriched (1S, 4R) 1-acetoxy-4-hydroxycyclopent-2-ene - Google Patents
Process for preparing enantiomerically enriched (1S, 4R) 1-acetoxy-4-hydroxycyclopent-2-ene Download PDFInfo
- Publication number
- ZA200505639B ZA200505639B ZA200505639A ZA200505639A ZA200505639B ZA 200505639 B ZA200505639 B ZA 200505639B ZA 200505639 A ZA200505639 A ZA 200505639A ZA 200505639 A ZA200505639 A ZA 200505639A ZA 200505639 B ZA200505639 B ZA 200505639B
- Authority
- ZA
- South Africa
- Prior art keywords
- pancreatin
- ene
- mixture
- reaction
- hydroxycyclopent
- Prior art date
Links
- IJDYOKVVRXZCFD-NKWVEPMBSA-N [(1s,4r)-4-hydroxycyclopent-2-en-1-yl] acetate Chemical compound CC(=O)O[C@H]1C[C@@H](O)C=C1 IJDYOKVVRXZCFD-NKWVEPMBSA-N 0.000 title claims description 12
- 238000004519 manufacturing process Methods 0.000 title description 4
- 108010019160 Pancreatin Proteins 0.000 claims description 51
- 229940055695 pancreatin Drugs 0.000 claims description 51
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 37
- 238000006243 chemical reaction Methods 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 19
- 239000002904 solvent Substances 0.000 claims description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 14
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 10
- 239000011541 reaction mixture Substances 0.000 claims description 8
- 239000004215 Carbon black (E152) Substances 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 229930195733 hydrocarbon Natural products 0.000 claims description 7
- 150000002430 hydrocarbons Chemical class 0.000 claims description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 230000001376 precipitating effect Effects 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- -1 methyl- Chemical group 0.000 claims description 3
- FVNIMHIOIXPIQT-UHFFFAOYSA-N 2-methoxybutane Chemical compound CCC(C)OC FVNIMHIOIXPIQT-UHFFFAOYSA-N 0.000 claims 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical class CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- IJDYOKVVRXZCFD-UHFFFAOYSA-N (4-hydroxycyclopent-2-en-1-yl) acetate Chemical compound CC(=O)OC1CC(O)C=C1 IJDYOKVVRXZCFD-UHFFFAOYSA-N 0.000 description 7
- 239000013078 crystal Substances 0.000 description 6
- 239000007858 starting material Substances 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 239000004367 Lipase Substances 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 229940040461 lipase Drugs 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000005809 transesterification reaction Methods 0.000 description 4
- 239000005909 Kieselgur Substances 0.000 description 3
- 102000019280 Pancreatic lipases Human genes 0.000 description 3
- 108050006759 Pancreatic lipases Proteins 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 3
- 150000003180 prostaglandins Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- OXMIDRBAFOEOQT-UHFFFAOYSA-N 2,5-dimethyloxolane Chemical compound CC1CCC(C)O1 OXMIDRBAFOEOQT-UHFFFAOYSA-N 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- VGMVMTKGFSFRLO-UHFFFAOYSA-N cyclopentene-1,2-diol Chemical compound OC1=C(O)CCC1 VGMVMTKGFSFRLO-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 2
- 239000000391 magnesium silicate Substances 0.000 description 2
- 229910052919 magnesium silicate Inorganic materials 0.000 description 2
- 235000019792 magnesium silicate Nutrition 0.000 description 2
- 229940116369 pancreatic lipase Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- CXBDYQVECUFKRK-UHFFFAOYSA-N 1-methoxybutane Chemical compound CCCCOC CXBDYQVECUFKRK-UHFFFAOYSA-N 0.000 description 1
- XHAXVDWUMCHTCY-UHFFFAOYSA-N 2,2,2-trichloroethyl acetate Chemical compound CC(=O)OCC(Cl)(Cl)Cl XHAXVDWUMCHTCY-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 238000003109 Karl Fischer titration Methods 0.000 description 1
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 239000012345 acetylating agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- IGRLIBJHDBWKNA-UHFFFAOYSA-N cyclopent-4-ene-1,3-diol Chemical compound OC1CC(O)C=C1 IGRLIBJHDBWKNA-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- YEMWINDXAKRPBK-UHFFFAOYSA-N heptane;2-methoxy-2-methylpropane Chemical compound COC(C)(C)C.CCCCCCC YEMWINDXAKRPBK-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940127293 prostanoid Drugs 0.000 description 1
- 150000003814 prostanoids Chemical class 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/94—Pancreatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43995303P | 2003-01-14 | 2003-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200505639B true ZA200505639B (en) | 2006-04-26 |
Family
ID=32713525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200505639A ZA200505639B (en) | 2003-01-14 | 2005-07-13 | Process for preparing enantiomerically enriched (1S, 4R) 1-acetoxy-4-hydroxycyclopent-2-ene |
Country Status (15)
Country | Link |
---|---|
US (1) | US6974834B2 (es) |
EP (1) | EP1587937A1 (es) |
JP (1) | JP2006514834A (es) |
KR (1) | KR20050100612A (es) |
CN (1) | CN1717492A (es) |
AR (1) | AR042848A1 (es) |
AU (1) | AU2004204226A1 (es) |
BR (1) | BRPI0406718A (es) |
CA (1) | CA2512121A1 (es) |
MX (1) | MXPA05007528A (es) |
PL (1) | PL378357A1 (es) |
RU (1) | RU2005122259A (es) |
TW (1) | TW200424313A (es) |
WO (1) | WO2004063384A1 (es) |
ZA (1) | ZA200505639B (es) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE293136C (es) * | ||||
DD290662A5 (de) * | 1989-12-22 | 1991-06-06 | Ve Fz Biotechnologie,De | Verfahren zur herstellung von (1s, 4r)-1-acyloxy-4-hydroxy-cyclopent-2-enen |
DD290663A5 (de) * | 1989-12-22 | 1991-06-06 | Ve Fz Biotechnologie,De | Verfahren zur herstellung von (1s, 4r)-1-acyloxy-4-hydroxy-cyclopent-2-enen |
-
2004
- 2004-01-05 MX MXPA05007528A patent/MXPA05007528A/es unknown
- 2004-01-05 RU RU2005122259/13A patent/RU2005122259A/ru not_active Application Discontinuation
- 2004-01-05 BR BR0406718-5A patent/BRPI0406718A/pt not_active IP Right Cessation
- 2004-01-05 PL PL378357A patent/PL378357A1/pl not_active Application Discontinuation
- 2004-01-05 AU AU2004204226A patent/AU2004204226A1/en not_active Abandoned
- 2004-01-05 JP JP2006500285A patent/JP2006514834A/ja not_active Withdrawn
- 2004-01-05 EP EP04700154A patent/EP1587937A1/en not_active Withdrawn
- 2004-01-05 CA CA002512121A patent/CA2512121A1/en not_active Abandoned
- 2004-01-05 CN CNA2004800016112A patent/CN1717492A/zh active Pending
- 2004-01-05 KR KR1020057012984A patent/KR20050100612A/ko not_active Application Discontinuation
- 2004-01-05 WO PCT/IB2004/000045 patent/WO2004063384A1/en not_active Application Discontinuation
- 2004-01-07 US US10/753,136 patent/US6974834B2/en not_active Expired - Fee Related
- 2004-01-13 TW TW093100785A patent/TW200424313A/zh unknown
- 2004-01-13 AR ARP040100081A patent/AR042848A1/es unknown
-
2005
- 2005-07-13 ZA ZA200505639A patent/ZA200505639B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL378357A1 (pl) | 2006-03-20 |
AR042848A1 (es) | 2005-07-06 |
RU2005122259A (ru) | 2006-01-20 |
MXPA05007528A (es) | 2005-09-21 |
JP2006514834A (ja) | 2006-05-18 |
CA2512121A1 (en) | 2004-07-29 |
US20040171129A1 (en) | 2004-09-02 |
CN1717492A (zh) | 2006-01-04 |
BRPI0406718A (pt) | 2005-12-20 |
AU2004204226A1 (en) | 2004-07-29 |
TW200424313A (en) | 2004-11-16 |
US6974834B2 (en) | 2005-12-13 |
EP1587937A1 (en) | 2005-10-26 |
KR20050100612A (ko) | 2005-10-19 |
WO2004063384A1 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2843606B2 (ja) | 不可逆的アシル基転移試薬としてエノールエステルを用いる有機化合物の鏡像異性および位置異性選択的合成 | |
Curran et al. | The preparation of optically active 2-cyclopenten-1, 4-diol derivatives from furfuryl alcohol | |
Oberhauser et al. | Enzymatic resolution of norbornane-type esters | |
JP2002532099A (ja) | 3,5−ジオキソカルボン酸、その塩およびそのエステルのr−選択還元法 | |
JP2542941B2 (ja) | 光学活性ヒドロキシラクトン類の製造方法 | |
Casati et al. | Synthesis of enantiomerically pure (R)-and (S)-1-benzoyloxypropane-2, 3-diol and revision of the stereochemical outcome of the Candida antarctica lipase-catalyzed benzoylation of glycerol | |
Naoshima et al. | Enzymatic preparation of enantiomerically pure alkan-2-and-3-ols by lipase-catalysed hydrolysis with Pseudomonas cepacia in the presence of organic media | |
Fujii et al. | Chemoenzymatic synthesis of optically active γ-alkyl-γ-butenolides | |
Franssen et al. | Resolution of a tetrahydrofuran ester by Candida rugosa lipase (CRL) and an examination of CRL's stereochemical preference in organic media | |
JPH06172276A (ja) | β−ラクタム前駆体からタキソール型化合物を製造する方法 | |
ZA200505639B (en) | Process for preparing enantiomerically enriched (1S, 4R) 1-acetoxy-4-hydroxycyclopent-2-ene | |
US5447865A (en) | Method of resolution of hydroxy substituted cyclopentanone enantiomers using lipase and lithium salt complexation | |
CN109161577A (zh) | 一种左旋Corey内酯二醇中间体、其制备方法及其药物应用 | |
AU670088B2 (en) | Enzymatic process to separate racemic mixtures of delta valerolactones | |
KR0150592B1 (ko) | 효소를 이용한 (r,s)-1,2-페닐에탄디올의 광학적 분할방법 | |
EP0435293B1 (en) | Methods of producing optically active hydroxyesters | |
Herradon | Influence of the nature of the solvent on the enantioselectivity of lipase-catalyzed transesterifications: a comparison between the lipases from porcine pancreas and Pseudomonas fluorescens | |
KR920006869B1 (ko) | 광학 활성 화합물 및 이의 제조방법 | |
Casati et al. | Enzymatic synthesis of both enantiomeric forms of 3-allyloxy-propane-1, 2-diol | |
US5107039A (en) | Optically active cyclopentenols and process for preparing the same | |
US5089176A (en) | Optically active monoester compounds and producing | |
DE69127219T2 (de) | Verfahren zur Herstellung von optisch aktiven Alkyl-3-aryl-3-hydroxypropionaten | |
Nakano et al. | Lipase-mediated kinetic resolution of cis-1, 2-indandiol and the Ritter reaction of its mono-acetate | |
JPH0634752B2 (ja) | 2−アルカノールの光学活性エステルの製造方法 | |
US5449793A (en) | Process for producing an optically active 1,5-disubstituted-2,4-O-isopropylidene-2,4-dihydroxypentane |